Considering adiponectin values measured with the ELLA method, we found an almost 4-fold increased breast cancer risk HR = 3.75 (95% CI: 1.37;10.25, p = 0.01) for subjects with low adiponectin values (below the lowest quartile) versus subjects with higher adiponectin (Figure 4A). The gene discussed is ADIPOQ; the disease is breast carcinoma.